德克萨米他可以通过miR-155缓解由 inguinal hernia meshes 引起的炎症反应
1Department of General Surgery, The First People's Hospital of Yunnan Province, Xishan District, No. 157, Jinbi Road, Kunming, 650032, Yunnan, China.
Hernia : the journal of hernias and abdominal wall surgery
|March 16, 2024
概括
德克萨米他 (DEX) 通过调节miR-155和JAK1/STAT3通路来减少 inguinal 网的炎症. 这项研究阐明了DEX如何减轻 inguinal 修复中的网状诱导炎症.
科学领域:
- 生物医学研究的研究.
- 手术方面的创新.
- 炎症和免疫学 炎症和免疫学
背景情况:
- 阴带修复经常涉及网状,这可能导致术后炎症.
- 德甲 (DEX) 是一种抗炎药物,但其在缓解网状炎症方面的精确机制尚未完全理解.
研究的目的:
- 研究甲 (DEX) 缓解与 inguinal hernia 网状放置相关的炎症的机制.
- 探索miR-155和JAK1/STAT3信号通路在DEX介导的抗炎作用中的作用.
主要方法:
- 使用鼠标模型的 inguinal 带聚烯网状植入物.
- 采用RT-qPCR,ELISA和西式涂抹来分析基因和蛋白质的表达 (miR-155,IL-1β,IL-6,IL-18,caspase-1,JAK1,p-JAK1,STAT3,p-STAT3).
- 进行了双化酶报告员测定,以确认miR-155和JAK1.1.之间的相互作用.
主要成果:
- 聚烯网状植入上调了miR-155,IL-1β,IL-6和IL-18的表达.
- DEX治疗显著降低了miR-155,caspase-1,IL-1β,IL-6和IL-18的水平.
- 证实miR-155针对JAK1进行下调,并且DEX的抗炎作用涉及通过JAK1/STAT3通路的这种相互作用.
结论:
- 德克萨米他 (DEX) 有效地减少由 inguinal 网引起的炎症.
- 德克斯的抗炎作用通过调节miR-155进行调节,这反过来又影响了JAK1/STAT3信号通路.
- 这项研究阐明了一个关键的分子机制,该机制是DEX在与网状炎症相关的治疗效果的基础.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294


